APO Research
Talk to an analyst

APO RESEARCH · REPORT

Amifostine

Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen under the trade name Ethyol.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen under the trade name Ethyol.

Selected research

Market Outlook & Growth Opportunities

Global Amifostine Market Outlook and Growth Opportunities 2026

9 January 2026197 pages

Choose your research edition.

Industry ResearchAmifostine Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Amifostine Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Amifostine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Amifostine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Amifostine Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen under the trade name Ethyol.

Global Amifostine key players include Sun Pharmaceutical, Clinigen Group, Merro Pharmaceutical, Taj Pharmaceuticals, Luye Pharma, etc. Global top five manufacturers hold a share over 90%. North America is the largest sales market, with a share over 50%, followed by Asia-Pacific with a share over 40 percent.

This report provides an overview of the global Amifostine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Amifostine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Amifostine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Amifostine market size, projected growth trends, production technologies, key applications, and end-use industries.

Amifostine Segment by Company

Clinigen

Sun Pharmaceutical

Taj Pharmaceuticals

Merro Pharmaceutical

Luye Pharma

Mingren Pharma

Amifostine Segment by Type

400mg/Dose

500mg/Dose

Amifostine Segment by Application

Head and Neck Cancer Adjuvant Therapy

Others

Amifostine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Amifostine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Amifostine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Amifostine significant trends, drivers, influence factors in global and regions.

6. To analyze Amifostine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amifostine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Amifostine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amifostine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Amifostine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Amifostine industry.

Chapter 3: Detailed analysis of Amifostine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Amifostine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Amifostine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Amifostine Industry Trends Table 2. Amifostine Industry Drivers Table 3. Amifostine Industry Opportunities and Challenges Table 4. Amifostine Industry Restraints Table 5. Global Amifostine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Amifostine Revenue Share by Company (2021-2026) Table 7. Global Amifostine Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Amifostine Sales Volume Share by Company (2021-2026) Table 9. Global Amifostine Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Amifostine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Amifostine Key Company Manufacturing Base & Headquarters Table 12. Global Amifostine Company, Product Type & Application Table 13. Global Amifostine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Amifostine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 400mg/Dose Table 18. Significant Companies of 500mg/Dose Table 19. Global Amifostine Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Amifostine Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Amifostine Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Amifostine Sales Volume Share by Type (2021-2026) Table 23. Global Amifostine Sales Volume Share by Type (2027-2032) Table 24. Global Amifostine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Amifostine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Amifostine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Amifostine Sales Value Share by Type (2021-2026) Table 28. Global Amifostine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Head and Neck Cancer Adjuvant Therapy Table 30. Significant Companies of Others Table 31. Global Amifostine Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Amifostine Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Amifostine Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Amifostine Sales Volume Share by Application (2021-2026) Table 35. Global Amifostine Sales Volume Share by Application (2027-2032) Table 36. Global Amifostine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Amifostine Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Amifostine Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Amifostine Sales Value Share by Application (2021-2026) Table 40. Global Amifostine Sales Value Share by Application (2027-2032) Table 41. Global Amifostine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Amifostine Sales by Region (2021-2026) & (K Units) Table 43. Global Amifostine Sales Market Share by Region (2021-2026) Table 44. Global Amifostine Sales by Region (2027-2032) & (K Units) Table 45. Global Amifostine Sales Market Share by Region (2027-2032) Table 46. Global Amifostine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Amifostine Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Amifostine Sales Value Share by Region (2021-2026) Table 49. Global Amifostine Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Amifostine Sales Value Share by Region (2027-2032) Table 51. Global Amifostine Market Average Price (USD/Unit) by Region (2021-2026) Table 52. Global Amifostine Market Average Price (USD/Unit) by Region (2027-2032) Table 53. Global Amifostine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Amifostine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Amifostine Sales by Country (2021-2026) & (K Units) Table 56. Global Amifostine Sales Market Share by Country (2021-2026) Table 57. Global Amifostine Sales by Country (2027-2032) & (K Units) Table 58. Global Amifostine Sales Market Share by Country (2027-2032) Table 59. Global Amifostine Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Amifostine Sales Value Market Share by Country (2021-2026) Table 61. Global Amifostine Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Amifostine Sales Value Market Share by Country (2027-2032) Table 63. Clinigen Company Information Table 64. Clinigen Business Overview Table 65. Clinigen Amifostine Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 66. Clinigen Amifostine Product Portfolio Table 67. Clinigen Recent Development Table 68. Sun Pharmaceutical Company Information Table 69. Sun Pharmaceutical Business Overview Table 70. Sun Pharmaceutical Amifostine Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 71. Sun Pharmaceutical Amifostine Product Portfolio Table 72. Sun Pharmaceutical Recent Development Table 73. Taj Pharmaceuticals Company Information Table 74. Taj Pharmaceuticals Business Overview Table 75. Taj Pharmaceuticals Amifostine Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. Taj Pharmaceuticals Amifostine Product Portfolio Table 77. Taj Pharmaceuticals Recent Development Table 78. Merro Pharmaceutical Company Information Table 79. Merro Pharmaceutical Business Overview Table 80. Merro Pharmaceutical Amifostine Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. Merro Pharmaceutical Amifostine Product Portfolio Table 82. Merro Pharmaceutical Recent Development Table 83. Luye Pharma Company Information Table 84. Luye Pharma Business Overview Table 85. Luye Pharma Amifostine Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 86. Luye Pharma Amifostine Product Portfolio Table 87. Luye Pharma Recent Development Table 88. Mingren Pharma Company Information Table 89. Mingren Pharma Business Overview Table 90. Mingren Pharma Amifostine Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 91. Mingren Pharma Amifostine Product Portfolio Table 92. Mingren Pharma Recent Development Table 93. Key Raw Materials Table 94. Raw Materials Key Suppliers Table 95. Amifostine Distributors List Table 96. Amifostine Customers List Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Amifostine Product Image Figure 2. Global Amifostine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Amifostine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Amifostine Sales (2021-2032) & (K Units) Figure 5. Global Amifostine Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Amifostine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 400mg/Dose Image Figure 10. 500mg/Dose Image Figure 11. Global Amifostine Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Amifostine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Amifostine Sales Volume Share by Type (2021-2032) Figure 14. Global Amifostine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Amifostine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Amifostine Sales Value Share by Type (2021-2032) Figure 17. Head and Neck Cancer Adjuvant Therapy Image Figure 18. Others Image Figure 19. Global Amifostine Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Amifostine Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Amifostine Sales Volume Share by Application (2021-2032) Figure 22. Global Amifostine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Amifostine Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Amifostine Sales Value Share by Application (2021-2032) Figure 25. Global Amifostine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Amifostine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Amifostine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Amifostine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Amifostine Sales Value (2021-2032) & (US$ Million) Figure 30. North America Amifostine Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Amifostine Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Amifostine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Amifostine Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Amifostine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Amifostine Sales Value (2021-2032) & (US$ Million) Figure 36. South America Amifostine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Amifostine Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Amifostine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Amifostine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Amifostine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Amifostine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Amifostine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Amifostine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Amifostine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Amifostine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Amifostine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Amifostine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Amifostine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Amifostine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Amifostine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Amifostine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Amifostine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Amifostine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Amifostine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Amifostine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Amifostine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Amifostine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Amifostine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Amifostine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Amifostine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Amifostine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Amifostine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Amifostine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Amifostine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Amifostine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Amifostine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Amifostine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Amifostine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Amifostine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Amifostine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Amifostine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Amifostine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Amifostine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Amifostine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Amifostine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Amifostine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Amifostine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Amifostine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Amifostine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Amifostine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Amifostine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Amifostine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Amifostine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Amifostine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Amifostine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Amifostine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Amifostine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Amifostine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Amifostine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Amifostine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Amifostine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Amifostine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Amifostine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Amifostine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Amifostine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Amifostine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Amifostine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Amifostine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Amifostine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Amifostine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Amifostine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Amifostine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Amifostine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Amifostine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Amifostine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Amifostine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Amifostine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Amifostine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Amifostine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Amifostine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Amifostine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Amifostine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Amifostine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Amifostine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Amifostine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Amifostine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Amifostine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Amifostine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Amifostine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Amifostine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Amifostine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Amifostine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Amifostine Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Amifostine Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • 400mg/Dose
  • 500mg/Dose
Applications
  • Head and Neck Cancer Adjuvant Therapy
  • Others
Companies covered
  • Clinigen
  • Sun Pharmaceutical
  • Taj Pharmaceuticals
  • Merro Pharmaceutical
  • Luye Pharma
  • Mingren Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Amifostine Sales Value (2021-2032)
  4. 1.2.2 Global Amifostine Sales Volume (2021-2032)
  5. 1.2.3 Global Amifostine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Amifostine Market Dynamics
  1. 2.1 Amifostine Industry Trends
  2. 2.2 Amifostine Industry Drivers
  3. 2.3 Amifostine Industry Opportunities and Challenges
  4. 2.4 Amifostine Industry Restraints
3 Amifostine Market by Company
  1. 3.1 Global Amifostine Company Revenue Ranking in 2025
  2. 3.2 Global Amifostine Revenue by Company (2021-2026)
  3. 3.3 Global Amifostine Sales Volume by Company (2021-2026)
  4. 3.4 Global Amifostine Average Price by Company (2021-2026)
  5. 3.5 Global Amifostine Company Ranking (2024-2026)
  6. 3.6 Global Amifostine Company Manufacturing Base and Headquarters
  7. 3.7 Global Amifostine Company Product Type and Application
  8. 3.8 Global Amifostine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Amifostine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Amifostine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Amifostine Market by Type
  1. 4.1 Amifostine Type Introduction
  2. 4.1.1 400mg/Dose
  3. 4.1.2 500mg/Dose
  4. 4.2 Global Amifostine Sales Volume by Type
  5. 4.2.1 Global Amifostine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Amifostine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Amifostine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Amifostine Sales Value by Type
  9. 4.3.1 Global Amifostine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Amifostine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Amifostine Sales Value Share by Type (2021-2032)
5 Amifostine Market by Application
  1. 5.1 Amifostine Application Introduction
  2. 5.1.1 Head and Neck Cancer Adjuvant Therapy
  3. 5.1.2 Others
  4. 5.2 Global Amifostine Sales Volume by Application
  5. 5.2.1 Global Amifostine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Amifostine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Amifostine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Amifostine Sales Value by Application
  9. 5.3.1 Global Amifostine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Amifostine Sales Value by Application (2021-2032)
  11. 5.3.3 Global Amifostine Sales Value Share by Application (2021-2032)
6 Amifostine Regional Sales and Value Analysis
  1. 6.1 Global Amifostine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Amifostine Sales by Region (2021-2032)
  3. 6.2.1 Global Amifostine Sales by Region: 2021-2026
  4. 6.2.2 Global Amifostine Sales by Region (2027-2032)
  5. 6.3 Global Amifostine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Amifostine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Amifostine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Amifostine Sales Value by Region (2027-2032)
  9. 6.5 Global Amifostine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Amifostine Sales Value (2021-2032)
  12. 6.6.2 North America Amifostine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Amifostine Sales Value (2021-2032)
  15. 6.7.2 Europe Amifostine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Amifostine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Amifostine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Amifostine Sales Value (2021-2032)
  21. 6.9.2 South America Amifostine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Amifostine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Amifostine Sales Value Share by Country, 2025 VS 2032
7 Amifostine Country-level Sales and Value Analysis
  1. 7.1 Global Amifostine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Amifostine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Amifostine Sales by Country (2021-2032)
  4. 7.3.1 Global Amifostine Sales by Country (2021-2026)
  5. 7.3.2 Global Amifostine Sales by Country (2027-2032)
  6. 7.4 Global Amifostine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Amifostine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Amifostine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Amifostine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Amifostine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Amifostine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Amifostine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Amifostine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Amifostine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Amifostine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Amifostine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Amifostine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Amifostine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Amifostine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Amifostine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Amifostine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Amifostine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Amifostine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Amifostine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Amifostine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Amifostine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Amifostine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Amifostine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Amifostine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Amifostine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Amifostine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Amifostine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Amifostine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Amifostine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Amifostine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Amifostine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Amifostine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Amifostine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Amifostine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Amifostine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Amifostine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Amifostine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Amifostine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Amifostine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Amifostine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Amifostine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Amifostine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Amifostine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Amifostine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Amifostine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Amifostine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Amifostine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Amifostine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Amifostine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Amifostine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Amifostine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Amifostine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Amifostine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Amifostine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Amifostine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Amifostine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Amifostine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Amifostine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Amifostine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Amifostine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Amifostine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Amifostine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Amifostine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Amifostine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Amifostine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Amifostine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Amifostine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Amifostine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Amifostine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Amifostine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Amifostine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Amifostine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Amifostine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Amifostine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Amifostine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Amifostine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Amifostine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Amifostine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Amifostine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Amifostine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Amifostine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Amifostine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Amifostine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Amifostine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Amifostine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Amifostine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Amifostine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Clinigen
  2. 8.1.1 Clinigen Company Information
  3. 8.1.2 Clinigen Business Overview
  4. 8.1.3 Clinigen Amifostine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Clinigen Amifostine Product Portfolio
  6. 8.1.5 Clinigen Recent Developments
  7. 8.2 Sun Pharmaceutical
  8. 8.2.1 Sun Pharmaceutical Company Information
  9. 8.2.2 Sun Pharmaceutical Business Overview
  10. 8.2.3 Sun Pharmaceutical Amifostine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sun Pharmaceutical Amifostine Product Portfolio
  12. 8.2.5 Sun Pharmaceutical Recent Developments
  13. 8.3 Taj Pharmaceuticals
  14. 8.3.1 Taj Pharmaceuticals Company Information
  15. 8.3.2 Taj Pharmaceuticals Business Overview
  16. 8.3.3 Taj Pharmaceuticals Amifostine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Taj Pharmaceuticals Amifostine Product Portfolio
  18. 8.3.5 Taj Pharmaceuticals Recent Developments
  19. 8.4 Merro Pharmaceutical
  20. 8.4.1 Merro Pharmaceutical Company Information
  21. 8.4.2 Merro Pharmaceutical Business Overview
  22. 8.4.3 Merro Pharmaceutical Amifostine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Merro Pharmaceutical Amifostine Product Portfolio
  24. 8.4.5 Merro Pharmaceutical Recent Developments
  25. 8.5 Luye Pharma
  26. 8.5.1 Luye Pharma Company Information
  27. 8.5.2 Luye Pharma Business Overview
  28. 8.5.3 Luye Pharma Amifostine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Luye Pharma Amifostine Product Portfolio
  30. 8.5.5 Luye Pharma Recent Developments
  31. 8.6 Mingren Pharma
  32. 8.6.1 Mingren Pharma Company Information
  33. 8.6.2 Mingren Pharma Business Overview
  34. 8.6.3 Mingren Pharma Amifostine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Mingren Pharma Amifostine Product Portfolio
  36. 8.6.5 Mingren Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Amifostine Value Chain Analysis
  2. 9.1.1 Amifostine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Amifostine Sales Mode & Process
  6. 9.2 Amifostine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Amifostine Distributors
  9. 9.2.3 Amifostine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst